Join speakers Nick Telischak, MD, MS and @eytanraz & moderator Ricardo Hanel, MD, PhD for “ASCENT Technique: A Shift in Aspiration Philosophy” 6/15 at 5PM ET. Thank you to @@route92med for sharing this webinar with our members. Register: https://t.co/lxcFOe3a0e
📣 Exciting news from Route 92: A major milestone powering global expansion, advancing clinical evidence, and fueling continued innovation. #ASCENTtechnique#globalstrokecare
Full press release – https://t.co/mGxTdcWfBW
🧠⚡️ Systematic review of 532 LVO patients shows super large bore aspiration catheters achieve high access (92%) and strong reperfusion (81%) with low complications, but modest first-pass effect (~55%) and reliance on non-randomized data highlight the need for larger prospective trials. Read more here: https://t.co/b6gHNIY6qN
@MagJablonska@marcriboj
Excellent case by Dr. Robinson and the
team at Mercy Jewish Hospital and
Mayfield Brain and Spine.
With HiPoint® 88 Reperfusion System
and Tenzing®-powered delivery,
controlled passive advancement
supported efficient clot extraction and
confident reperfusion.
#poweredbytenzing
#ASCENTtechnique
During Brain Awareness Week, we’re reminded just how critical time is when it comes to stroke care.
From recognition to reperfusion, every step plays a role in patient outcomes. Speed, control, and consistency aren’t just ideals—they’re necessities.
At Route 92, we’re committed to advancing techniques and technologies that support physicians in restoring flow—efficiently and effectively.
🧠 Know the signs.
⏰ Act fast.
❤️ Protect the brain.
#BrainAwarenessWeek #StrokeAwareness #MedTech #Neurointervention #Route92 #PatientOutcomes
HiPoint Reperfusion System is "pushing the boundaries" of stroke thrombectomy treatments (Ajit Puri)
#ASCENTtechnique#poweredbytenzing
This post is sponsored by Route 92 Medical.
https://t.co/C5Et3jbsMc
Though both Sir Edmund Hillary of New Zealand and Tenzing Norgay reached the summit of Everest together, history has largely spotlighted Hillary. https://t.co/6U6USgche6
THE MATCH THAT MATTERS: Vessel-optimized catheters enable consistent, safe delivery, supporting your first-pass success in #stroke patients. Visit https://t.co/fzBtk41UGT
Join us TODAY for our WebNIR - HiPoint in the Real World: Proven Techniques for the Monopoint Approach 🧠 https://t.co/gCNujgOkys
📅 October 22, 2025 | 🕒 3:00 PM CT
Registration is free and open to all!
#SVIN#WebNIR#StrokeCare#NeuroIntervention#Thrombectomy
Congratulations to Fairfax Radiological Consultants and Inova Fairfax Hospital on a successful first M1 occlusion case using the #HiPoint 88 Reperfusion System, #Tenzing 8 Delivery Catheter, and the 8F Base Camp Sheath!
Thank you for demonstrating safe and effective treatment of an .088" catheter in the M1 with TICI 3 results using the Monopoint Approach!
Learn more about HiPoint 88 Reperfusion System: https://t.co/1LS3rL2qgJ
#MonopointMonday #FirstAndOnly
Dr. Michael Robinson at Mercy Health, Mayfield Brain & Spine performs successful intervention with #TICI3 results at the #M1 using the #HiPoint 88 Reperfusion System, #Tenzing 8 Delivery Catheter, and the 8F Base Camp 2.0 sheath.
Thank you to Dr. Robinson and team for demonstrating a great .088" to M1 case using the Monopoint Approach!
Learn more about HiPoint 88 Reperfusion System: https://t.co/oFxoSVmzRj
#MonopointMonday #FirstAndOnly
Before SUMMIT MAX: Can an 0.088” be delivered to the M1 consistently?
After SUMMIT MAX: Yes, it can.
As the First and Only randomized controlled trial comparing aspiration thrombectomy devices, #SUMMIT_MAX proves it.
Dr. Ajit Puri highlights how the #HiPoint Reperfusion System, powered by #Tenzing Delivery, makes predictable 0.088” delivery to the MCA a reality — redefining what’s possible in stroke care.
👉Read the full NeuroNews article: https://t.co/rn4DxZCBhK
#PoweredByTenzing #FirstAndOnly